190 related articles for article (PubMed ID: 30654376)
1. Structural and Functional Characterization of the Retinal Effects of Hydroxychloroquine Treatment in Healthy Eyes.
Gil P; Nunes A; Farinha C; Teixeira D; Pires I; Silva R
Ophthalmologica; 2019; 241(4):226-233. PubMed ID: 30654376
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Retinal Changes Induced by Hydroxychloroquine in Eyes without Retinal Toxicity.
Godinho G; Madeira C; Falcão M; Penas S; Dinah-Bragança T; Brandão E; Carneiro Â; Santos-Silva R; Falcão-Reis F; Beato J
Ophthalmic Res; 2021; 64(2):290-296. PubMed ID: 32932260
[TBL] [Abstract][Full Text] [Related]
3. Comparison of screening procedures in hydroxychloroquine toxicity.
Marmor MF
Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
[TBL] [Abstract][Full Text] [Related]
4. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
de Sisternes L; Hu J; Rubin DL; Marmor MF
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
[TBL] [Abstract][Full Text] [Related]
5. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
6. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
[TBL] [Abstract][Full Text] [Related]
7. Effect of disease stage on progression of hydroxychloroquine retinopathy.
Marmor MF; Hu J
JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Maculopathy in Patients Using Hydroxychloroquine.
Uğurlu A; Aslanova M; Cebeci Z; Kır Mercül N
Turk J Ophthalmol; 2019 Jun; 49(3):149-153. PubMed ID: 31245977
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
11. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
[TBL] [Abstract][Full Text] [Related]
12. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM
Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304
[TBL] [Abstract][Full Text] [Related]
13. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
[TBL] [Abstract][Full Text] [Related]
14. Macular ganglion cell-inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine.
Kan E; Yakar K; Demirag MD; Gok M
Int Ophthalmol; 2018 Aug; 38(4):1635-1640. PubMed ID: 28695378
[TBL] [Abstract][Full Text] [Related]
15. Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients.
Ahn SJ; Joung J; Lim HW; Lee BR
Am J Ophthalmol; 2017 Dec; 184():11-18. PubMed ID: 28964805
[TBL] [Abstract][Full Text] [Related]
16. VOLUMETRIC SINGLE-LAYER INNER RETINAL ANALYSIS IN PATIENTS WITH HYDROXYCHLOROQUINE TOXICITY.
Modi YS; Au A; Parikh VS; Ehlers JP; Schachat AP; Singh RP
Retina; 2016 Oct; 36(10):1941-50. PubMed ID: 27258672
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
Ahn SJ; Seo EJ; Kim KE; Kim YJ; Lee BR; Kim JG; Yoon YH; Lee JY
Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843
[TBL] [Abstract][Full Text] [Related]
18. The optical coherence tomography angiography findings of rheumatoid arthritis patients taking hydroxychloroquine.
Ozek D; Onen M; Karaca EE; Omma A; Kemer OE; Coskun C
Eur J Ophthalmol; 2019 Sep; 29(5):532-537. PubMed ID: 30229672
[TBL] [Abstract][Full Text] [Related]
19. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity.
Melles RB; Marmor MF
Ophthalmology; 2015 Jan; 122(1):110-6. PubMed ID: 25182842
[TBL] [Abstract][Full Text] [Related]
20. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
Jayakar G; De Silva T; Cukras CA
Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):15. PubMed ID: 35015028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
